Bottom line
Is REVAX a good fund? The bottom line
REVAX is the Class A share class of RBC Emerging Markets Value Equity Fund, a managed emerging markets mutual fund from Rbc.
It charges 1.21% — about $121 a year on every $10,000 invested, more expensive than 66% of emerging markets funds we track.
It returned +38.5% over one year, +6.5% a year over five years (as of Dec 31, 2025, per its prospectus).
With $119 million in net assets and 80 holdings, its largest position is Taiwan Semiconductor Manufacturing Company Ltd (9.8%) and the top 10 make up 44.3% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 83% of category peers
What to watch
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What REVAX invests in
The Fund seeks to provide long-term capital growth.
The Fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its assets in equity securities tied economically to emerging market countries that are considered to be undervalued in relation to earnings, dividends and/or assets. For purposes of this policy, the term assets means net assets plus the amount of borrowings for investment purposes. A security is economically tied to an emerging market country if it is issued by a foreign government (or any political subdivision, agency, authority or instrumentality of such government) or corporation and the security is principally traded on the emerging market countrys securities markets, the classifications assigned by third parties, including an issuers country of issue as determined by Bloomberg and/or the classifications assigned to an issuer by the Funds benchmark index provider or a…
From the fund's prospectus (filed Jul 28, 2026).
REVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| REVAX | +38.5% | +6.5% | — |
| Emerging Markets median | +27.8% | +3.0% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What REVAX costs
On a $10,000 investment, REVAX's 1.21% expense ratio costs about $121 a year. The prospectus estimates $9,789 in total costs over 10 years (assuming 5% annual returns). The median emerging markets fund charges 1.02%.
REVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Company Ltd 2330 | 9.83% |
| 2 | Samsung Electronics Co Ltd 005935 | 9.31% |
| 3 | Sk Hynix Inc 000660 | 6.89% |
| 4 | Ase Technology Holding Co Ltd 3711 | 4.15% |
| 5 | Tencent Holdings Ltd 700 | 3.11% |
| 6 | Axis Bank Ltd AXSB | 2.62% |
| 7 | Alibaba Group Holding Ltd 9988 | 2.40% |
| 8 | China Resources Land Ltd 1109 | 2.25% |
| 9 | China Merchants Bank Company Ltd 3968 | 1.95% |
| 10 | Innodisk Corp 5289 | 1.83% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 44.3% of the fund. See all top 25 holdings and asset mix →